| Name | Count |
|---|
...Sanofi-Aventis Deutschland GmbH told the Federal Circuit on Friday that a California federal court...
... pharmaceutical giant Sanofi-Aventis. The plaintiffs are represented by Neblett Beard & Arsenault...
... rights to ask for additional information before approving a generic version of Sanofi-Aventis SA...
..., Johnson & Johnson, GlaxoSmithKline PLC, Novartis AG, Sanofi-Aventis SA, Wyeth and Merck & Co. Inc...
... Sanofi-Aventis SA. The transaction, which closed in April, was one beset with shareholder...
...A former Sanofi-Aventis U.S. LLC research chemist pled guilty Tuesday in New Jersey federal court...
... and acquisitions team attracted serious business in 2011, including representing Sanofi-Aventis SA in its $20.1...
..., either party may seek to reopen the litigation,” the stipulation said. Sanofi-Aventis...
... against drugmakers Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC over injuries and deaths allegedly...
... representing Sandoz Inc. in its efforts to continue to sell a generic version of Sanofi-Aventis SA...
... by Aventis. Aventis merged with Sanofi-Synthelabo in 2004 to form Sanofi-Aventis, and is now...
... giant Sanofi-Aventis SA and their predecessors of negligently burying evidence showing thalidomide...
... regulators announced in September that six pharmaceutical companies, including domestic units of Sanofi-Aventis...
... Sandoz competes for sales only with Sanofi-Aventis, which makes the brand-name drug Lovenox, and argued...
... the U.S. wing of French drug giant Sanofi-Aventis SA and Avantor Performance Materials Inc., successors...
... drugmaker partners Sanofi-Aventis SA and Bristol-Myers Squibb Co. $108 million in prejudgment interest...
...-judgment interest, and attorneys' fees and costs. Merial — a subsidiary of Sanofi-Aventis SA...
... a generic version of Tarka, which is covered by a Sanofi-Aventis Deutschland GmbH-owned patent...
... alleged insider trading connected to the 2009 merger of Sanofi-Aventis and Chattem Inc., finding...
... of a recently approved competing generic version of Sanofi-Aventis SA's anticoagulant Lovenox.